Mualliflar

  • Фотима Бахтиёровна Ахмедова
  • Дилфуза Сабуровна Маткаримова
  • Кодиржон Тухтабоевич Бобоев

##semicolon##

IL–6 – (C–174G), полиморфизм, провоспалительный цитокин, острый лейкоз, апоптоз, риск развития.

##submission.citations##

Bănescu C. еt al. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia //Cancer medicine. – 2019. – Т. 8. – №. 12. – С. 5492–5506.

Bharti R., Dey G., Mandal M. Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL–6 mediated involvement //Cancer letters. – 2016. – Т. 375. – №. 1. – С. 51–61.

Chonov D. C. et al. IL–6 activities in the tumour microenvironment. Part 1 //Open access Macedonian journal of medical sciences. – 2019. – Т. 7. – №. 14. – С. 2391.

Harun–Or–Roshid M. et al. Statistical meta–analysis to investigate the association between the Interleukin–6 (IL–6) gene polymorphisms and cancer risk //PloS one. – 2021. – Т. 16. – №. 3. – С. e0247055.

Kumari N. et al. Role of interleukin–6 in cancer progression and therapeutic resistance //Tumor Biology. – 2016. – Т. 37. – С. 11553–11572.

Liu R. T. et al. Correlations of IL–6 and IL–10 gene polymorphisms with childhood acute lymphoblastic leukemia //European Review for Medical & Pharmacological Sciences. – 2020. – Т. 24. – №. 15.

Liu T. Z. et al. Meta–analysis of the role of IL–6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies //Medicine. – 2017. – Т. 96. – №. 11. – С. e6126.

Nursal A. F. et al. The associations of IL–6, IFN–γ, TNF–α, IL–10, and TGF–β1 functional variants with acute myeloid leukemia in Turkish patients //Genetic testing and molecular biomarkers. – 2016. – Т. 20. – №. 9. – С. 544–551.

Rašková M. et al. The role of IL–6 in cancer cell invasiveness and metastasis—overview and therapeutic opportunities //Cells. – 2022. – Т. 11. – №. 22. – С. 3698.

Zhou L. et al. Associations of interleukin–6 gene polymorphisms with cancer risk: evidence based on 49,408 cancer cases and 61,790 controls //Gene. – 2018. – Т. 670. – С. 136–147.